Representative before the EPO

Company dna cabinet lecca
no operation time available
411.14
1 office
active in Legal Services

Patricia S. Lecca has worked on the following 33 EPO patent applications which have been published in the last five years:

EP11726502

A NOVEL PROCESS FOR PREPARATION OF BOSENTAN

IPC classification:
A61K 31/505, A61P 11/00, C07D 239/545
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION IN PROGRESS
EP11837675

PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE

IPC classification:
A61K 31/4184, A61P 35/00, C07D 235/16
Agent:
Ibrahim Iskender, Destek Patent Inc
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP11842990

FINGOLIMOD POLYMORPHS AND THEIR PROCESSES

IPC classification:
A61K 31/137, A61P 37/02, C07C 213/00, C07C 215/28
Agent:
Ibrahim Iskender, Destek Patent Inc
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION IN PROGRESS
EP11173119

Combination vaccine with whole cell pertussis

IPC classification:
A61K 39/05, A61K 39/08, A61K 39/10, A61K 39/102, A61K 39/13, A61K 39/29
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11172591

Combination vaccine with acellular pertussis

IPC classification:
A61K 39/05, A61K 39/08, A61K 39/10, A61K 39/102, A61K 39/13, A61K 39/29
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11777945

RAPID GENOTYPING ANALYSIS FOR HUMAN PAPILLOMAVIRUS AND THE DEVICE THEREOF

IPC classification:
C12Q 1/70, G01N 33/48
Agent:
Patricia S. Lecca, Cabinet Lecca
Agent:
inCompass IP Europe Ltd
Status:
EXAMINATION IN PROGRESS
EP12828954

SYSTEM AND METHOD FOR LOCATING AND IDENTIFYING FUNCTIONAL NERVES INNERVATING WALL OF ARTERIES AND CATHETERS FOR SAME

IPC classification:
A61B 5/00, A61B 18/14
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP13150187

SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF

IPC classification:
A61K 38/44, A61K 47/48, A61P 17/00, A61P 17/16, A61P 35/00, C12N 9/02
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Victor Segalen Bordeaux 2
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12834337

BEVERAGE SYSTEM WITH AERATION

IPC classification:
A47J 31/00, B67D 1/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
PATENT GRANTED
EP12833609

ENERGY MANAGEMENT SYSTEM

IPC classification:
G01R 22/00, H04W 24/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14181904

Compositions comprising calcium, magnesium, zinc, and vitamin D3 for the prevention and amelioration of osteoporosis

IPC classification:
A61K 31/593, A61K 33/06, A61K 33/30, A61P 19/10, A61P 43/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP12771074

CENTRIFUGAL FLUID RING REACTOR

IPC classification:
B01F 7/00, B01J 8/10, B01J 19/08, B01J 19/18, C10G 29/20, C10L 1/02
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP13760612

VAGINAL REMODELING DEVICE AND METHOD

IPC classification:
A61B 18/02
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION IN PROGRESS
EP13720262

POLYPEPTIDES AS APELIN INHIBITORS AND USES THEREOF

IPC classification:
C07K 14/47
Applicant:
Université de Bordeaux
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Denise Marie Hirsch, Inserm Transfert
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION IN PROGRESS
EP14191824

Integrated stacking device and conveyor

IPC classification:
B65G 60/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12183621

Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

IPC classification:
A61K 35/74, A61P 1/00, A61P 11/00, A61P 11/06, A61P 13/00, A61P 31/04, A61P 37/08, C12N 1/06, C12N 1/20, C12R 1/225, C12R 1/25
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12877327

PROCESS FOR PREPARING CRYSTALLINE SORAFENIB TOSYLATE

IPC classification:
A61K 31/44, A61P 35/00, C07D 213/81
Agent:
Ibrahim Iskender, Destek Patent Inc
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP14700063

SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF

IPC classification:
A61K 38/44, A61K 47/48, A61P 17/00, A61P 17/16, A61P 35/00, C12N 9/02
Applicant:
Université de Bordeaux
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP14740925

DEVICE FOR RELIABLY MOVING ARTICLE FROM CONVEYOR SURFACE

IPC classification:
B65G 47/82
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP14741170

PROCESS FOR PREPARATION OF FINGOLIMOD AND ITS SALTS

IPC classification:
C07C 209/50, C07C 211/17, C07C 215/28
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP14822663

ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING IMATINIB MESYLATE

IPC classification:
A61K 9/16, A61K 9/20
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP15152886

New compositions and methods of treating and/or preventing chronic obstructive pulmonary disease

IPC classification:
A61K 31/198, A61K 31/395, A61K 31/4995, A61K 45/06, A61P 11/00
Applicant:
Université de Bordeaux
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire de Bordeaux
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15155202

Novel voltage dependent ion channel fusions and method of use thereof

IPC classification:
C07K 14/705, G01N 33/542
Applicant:
Université de Bordeaux
Applicant:
Institut Polytechnique de Bordeaux
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP12180334

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Patricia S. Lecca, Cabinet Lecca
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12180487

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Patricia S. Lecca, Cabinet Lecca
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12180375

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Patricia S. Lecca, Cabinet Lecca
Agent:
Philippe Becker, Cabinet Becker & Associés
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14864924

PROCESS FOR CRYSTALLINE PEMETREXED DIPOTASSIUM SALT

IPC classification:
A61K 31/519
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP10840176

IMMUNOPROTECTION BY ORAL ADMINISTRATION OF RECOMBINANT LACTOCOCCUS LACTIS MINI-CAPSULES

IPC classification:
A61K 39/00, A61K 39/145
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15188615

NOVEL METHODS AND KITS FOR DETECTING OF UREA CYCLE DISORDERS USING MASS SPECTROMETRY

IPC classification:
G01N 33/58, G01N 33/68
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
Request for examination was made
EP15729243

HIGH THROUGHPUT QUANTIFICATION AND CHARACTERIZATION OF VIRUSES AND PRODUCTS THEREOF

IPC classification:
C12N 7/00, G01N 15/02, G01N 21/49, G01N 30/46
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15815760

PEMETREXED DIPOTASSIUM FORMULATIONS

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15819144

AN IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE

IPC classification:
C07D 233/86
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15862402

SUBSTANTIALLY PURE VEMURAFENIB AND ITS SALTS

IPC classification:
A61K 31/437, C07D 471/04
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
Request for examination was made

Please Sign in to use this feature